Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Aniko Sabo is active.

Publication


Featured researches published by Aniko Sabo.


Nature | 2008

Somatic mutations affect key pathways in lung adenocarcinoma

Li Ding; Gad Getz; David A. Wheeler; Elaine R. Mardis; Michael D. McLellan; Kristian Cibulskis; Carrie Sougnez; Heidi Greulich; Donna M. Muzny; Margaret Morgan; Lucinda Fulton; Robert S. Fulton; Qunyuan Zhang; Michael C. Wendl; Michael S. Lawrence; David E. Larson; Ken Chen; David J. Dooling; Aniko Sabo; Alicia Hawes; Hua Shen; Shalini N. Jhangiani; Lora Lewis; Otis Hall; Yiming Zhu; Tittu Mathew; Yanru Ren; Jiqiang Yao; Steven E. Scherer; Kerstin Clerc

Determining the genetic basis of cancer requires comprehensive analyses of large collections of histopathologically well-classified primary tumours. Here we report the results of a collaborative study to discover somatic mutations in 188 human lung adenocarcinomas. DNA sequencing of 623 genes with known or potential relationships to cancer revealed more than 1,000 somatic mutations across the samples. Our analysis identified 26 genes that are mutated at significantly high frequencies and thus are probably involved in carcinogenesis. The frequently mutated genes include tyrosine kinases, among them the EGFR homologue ERBB4; multiple ephrin receptor genes, notably EPHA3; vascular endothelial growth factor receptor KDR; and NTRK genes. These data provide evidence of somatic mutations in primary lung adenocarcinoma for several tumour suppressor genes involved in other cancers—including NF1, APC, RB1 and ATM—and for sequence changes in PTPRD as well as the frequently deleted gene LRP1B. The observed mutational profiles correlate with clinical features, smoking status and DNA repair defects. These results are reinforced by data integration including single nucleotide polymorphism array and gene expression array. Our findings shed further light on several important signalling pathways involved in lung adenocarcinoma, and suggest new molecular targets for treatment.


Nature | 2012

Patterns and rates of exonic de novo mutations in autism spectrum disorders

Benjamin M. Neale; Yan Kou; Li Liu; Avi Ma'ayan; Kaitlin E. Samocha; Aniko Sabo; Chiao-Feng Lin; Christine Stevens; Li-San Wang; Vladimir Makarov; Pazi Penchas Polak; Seungtai Yoon; Jared Maguire; Emily L. Crawford; Nicholas G. Campbell; Evan T. Geller; Otto Valladares; Chad Shafer; Han Liu; Tuo Zhao; Guiqing Cai; Jayon Lihm; Ruth Dannenfelser; Omar Jabado; Zuleyma Peralta; Uma Nagaswamy; Donna M. Muzny; Jeffrey G. Reid; Irene Newsham; Yuanqing Wu

Autism spectrum disorders (ASD) are believed to have genetic and environmental origins, yet in only a modest fraction of individuals can specific causes be identified. To identify further genetic risk factors, here we assess the role of de novo mutations in ASD by sequencing the exomes of ASD cases and their parents (n = 175 trios). Fewer than half of the cases (46.3%) carry a missense or nonsense de novo variant, and the overall rate of mutation is only modestly higher than the expected rate. In contrast, the proteins encoded by genes that harboured de novo missense or nonsense mutations showed a higher degree of connectivity among themselves and to previous ASD genes as indexed by protein-protein interaction screens. The small increase in the rate of de novo events, when taken together with the protein interaction results, are consistent with an important but limited role for de novo point mutations in ASD, similar to that documented for de novo copy number variants. Genetic models incorporating these data indicate that most of the observed de novo events are unconnected to ASD; those that do confer risk are distributed across many genes and are incompletely penetrant (that is, not necessarily sufficient for disease). Our results support polygenic models in which spontaneous coding mutations in any of a large number of genes increases risk by 5- to 20-fold. Despite the challenge posed by such models, results from de novo events and a large parallel case–control study provide strong evidence in favour of CHD8 and KATNAL2 as genuine autism risk factors.


Nucleic Acids Research | 2004

WormBase: a multi-species resource for nematode biology and genomics.

Todd W. Harris; Nansheng Chen; Fiona Cunningham; Marcela K. Tello-Ruiz; Igor Antoshechkin; Carol Bastiani; Tamberlyn Bieri; Darin Blasiar; Keith Bradnam; Juancarlos Chan; Chao-Kung Chen; Wen J. Chen; Paul H. Davis; Eimear E. Kenny; Ranjana Kishore; Daniel Lawson; Raymond Y. N. Lee; Hans-Michael Müller; Cecilia Nakamura; Philip Ozersky; Andrei Petcherski; Anthony Rogers; Aniko Sabo; Erich M. Schwarz; Kimberly Van Auken; Qinghua Wang; Richard Durbin; John Spieth; Paul W. Sternberg; Lincoln Stein

WormBase (http://www.wormbase.org/) is the central data repository for information about Caenorhabditis elegans and related nematodes. As a model organism database, WormBase extends beyond the genomic sequence, integrating experimental results with extensively annotated views of the genome. The WormBase Consortium continues to expand the biological scope and utility of WormBase with the inclusion of large-scale genomic analyses, through active data and literature curation, through new analysis and visualization tools, and through refinement of the user interface. Over the past year, the nearly complete genomic sequence and comparative analyses of the closely related species Caenorhabditis briggsae have been integrated into WormBase, including gene predictions, ortholog assignments and a new synteny viewer to display the relationships between the two species. Extensive site-wide refinement of the user interface now provides quick access to the most frequently accessed resources and a consistent browsing experience across the site. Unified single-page views now provide complete summaries of commonly accessed entries like genes. These advances continue to increase the utility of WormBase for C.elegans researchers, as well as for those researchers exploring problems in functional and comparative genomics in the context of a powerful genetic system.


Nature Genetics | 2014

A framework for the interpretation of de novo mutation in human disease

Kaitlin E. Samocha; Elise B. Robinson; Stephan J. Sanders; Christine Stevens; Aniko Sabo; Lauren M. McGrath; Jack A. Kosmicki; Karola Rehnström; Swapan Mallick; Andrew Kirby; Dennis P. Wall; Daniel G. MacArthur; Stacey Gabriel; Mark A. DePristo; Shaun Purcell; Aarno Palotie; Eric Boerwinkle; Joseph D. Buxbaum; Edwin H. Cook; Richard A. Gibbs; Gerard D. Schellenberg; James S. Sutcliffe; Bernie Devlin; Kathryn Roeder; Benjamin M. Neale; Mark J. Daly

Spontaneously arising (de novo) mutations have an important role in medical genetics. For diseases with extensive locus heterogeneity, such as autism spectrum disorders (ASDs), the signal from de novo mutations is distributed across many genes, making it difficult to distinguish disease-relevant mutations from background variation. Here we provide a statistical framework for the analysis of excesses in de novo mutation per gene and gene set by calibrating a model of de novo mutation. We applied this framework to de novo mutations collected from 1,078 ASD family trios, and, whereas we affirmed a significant role for loss-of-function mutations, we found no excess of de novo loss-of-function mutations in cases with IQ above 100, suggesting that the role of de novo mutations in ASDs might reside in fundamental neurodevelopmental processes. We also used our model to identify ∼1,000 genes that are significantly lacking in functional coding variation in non-ASD samples and are enriched for de novo loss-of-function mutations identified in ASD cases.


Nature Genetics | 2004

Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid.

Michael McClelland; Kenneth E. Sanderson; Sandra W. Clifton; Phil Latreille; Steffen Porwollik; Aniko Sabo; Rekha Meyer; Tamberlyn Bieri; Phil Ozersky; Michael D. McLellan; C Richard Harkins; Chunyan Wang; Christine Nguyen; Amy Berghoff; Glendoria Elliott; Sara Kohlberg; Cindy Strong; Feiyu Du; Jason Carter; Colin Kremizki; Dan Layman; Shawn Leonard; Hui Sun; Lucinda Fulton; William E. Nash; Tracie L. Miner; Patrick Minx; Kim D. Delehaunty; Catrina C. Fronick; Vincent Magrini

Salmonella enterica serovars often have a broad host range, and some cause both gastrointestinal and systemic disease. But the serovars Paratyphi A and Typhi are restricted to humans and cause only systemic disease. It has been estimated that Typhi arose in the last few thousand years. The sequence and microarray analysis of the Paratyphi A genome indicates that it is similar to the Typhi genome but suggests that it has a more recent evolutionary origin. Both genomes have independently accumulated many pseudogenes among their ∼4,400 protein coding sequences: 173 in Paratyphi A and ∼210 in Typhi. The recent convergence of these two similar genomes on a similar phenotype is subtly reflected in their genotypes: only 30 genes are degraded in both serovars. Nevertheless, these 30 genes include three known to be important in gastroenteritis, which does not occur in these serovars, and four for Salmonella-translocated effectors, which are normally secreted into host cells to subvert host functions. Loss of function also occurs by mutation in different genes in the same pathway (e.g., in chemotaxis and in the production of fimbriae).


Nature Communications | 2010

Deep resequencing reveals excess rare recent variants consistent with explosive population growth

Alex Coventry; Lara M. Bull-Otterson; Xiaoming Liu; Andrew G. Clark; Taylor J. Maxwell; Jacy R. Crosby; James E. Hixson; Thomas J. Rea; Donna M. Muzny; Lora Lewis; David A. Wheeler; Aniko Sabo; Christine M. Lusk; Kenneth G. Weiss; Humeira Akbar; Andrew Cree; Alicia Hawes; Irene Newsham; Robin Varghese; Donna Villasana; Shannon Gross; Vandita Joshi; Jireh Santibanez; Margaret Morgan; Kyle Chang; Walker Hale; Alan R. Templeton; Eric Boerwinkle; Richard A. Gibbs; Charles F. Sing

Accurately determining the distribution of rare variants is an important goal of human genetics, but resequencing of a sample large enough for this purpose has been unfeasible until now. Here, we applied Sanger sequencing of genomic PCR amplicons to resequence the diabetes-associated genes KCNJ11 and HHEX in 13,715 people (10,422 European Americans and 3,293 African Americans) and validated amplicons potentially harbouring rare variants using 454 pyrosequencing. We observed far more variation (expected variant-site count ∼578) than would have been predicted on the basis of earlier surveys, which could only capture the distribution of common variants. By comparison with earlier estimates based on common variants, our model shows a clear genetic signal of accelerating population growth, suggesting that humanity harbours a myriad of rare, deleterious variants, and that disease risk and the burden of disease in contemporary populations may be heavily influenced by the distribution of rare variants.


Nucleic Acids Research | 2004

WormBase: a comprehensive data resource for Caenorhabditis biology and genomics

Nansheng Chen; Todd W. Harris; Igor Antoshechkin; Carol Bastiani; Tamberlyn Bieri; Darin Blasiar; Keith Bradnam; Payan Canaran; Juancarlos Chan; Chao-Kung Chen; Wen J. Chen; Fiona Cunningham; Paul H. Davis; Eimear E. Kenny; Ranjana Kishore; Daniel Lawson; Raymond Y. N. Lee; Hans-Michael Müller; Cecilia Nakamura; Shraddha Pai; Philip Ozersky; Andrei Petcherski; Anthony Rogers; Aniko Sabo; Erich M. Schwarz; Kimberly Van Auken; Qinghua Wang; Richard Durbin; John Spieth; Paul W. Sternberg

WormBase (http://www.wormbase.org), the model organism database for information about Caenorhabditis elegans and related nematodes, continues to expand in breadth and depth. Over the past year, WormBase has added multiple large-scale datasets including SAGE, interactome, 3D protein structure datasets and NCBI KOGs. To accommodate this growth, the International WormBase Consortium has improved the user interface by adding new features to aid in navigation, visualization of large-scale datasets, advanced searching and data mining. Internally, we have restructured the database models to rationalize the representation of genes and to prepare the system to accept the genome sequences of three additional Caenorhabditis species over the coming year.


Neuron | 2013

Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders.

Elaine T. Lim; Soumya Raychaudhuri; Stephan J. Sanders; Christine Stevens; Aniko Sabo; Daniel G. MacArthur; Benjamin M. Neale; Andrew Kirby; Douglas M. Ruderfer; Menachem Fromer; Monkol Lek; Li Liu; Jason Flannick; Stephan Ripke; Uma Nagaswamy; Donna M. Muzny; Jeffrey G. Reid; Alicia Hawes; Irene Newsham; Yuanqing Wu; Lora Lewis; Huyen Dinh; Shannon Gross; Li-San Wang; Chiao-Feng Lin; Otto Valladares; Stacey Gabriel; Mark A. DePristo; David Altshuler; Shaun Purcell

To characterize the role of rare complete human knockouts in autism spectrum disorders (ASDs), we identify genes with homozygous or compound heterozygous loss-of-function (LoF) variants (defined as nonsense and essential splice sites) from exome sequencing of 933 cases and 869 controls. We identify a 2-fold increase in complete knockouts of autosomal genes with low rates of LoF variation (≤ 5% frequency) in cases and estimate a 3% contribution to ASD risk by these events, confirming this observation in an independent set of 563 probands and 4,605 controls. Outside the pseudoautosomal regions on the X chromosome, we similarly observe a significant 1.5-fold increase in rare hemizygous knockouts in males, contributing to another 2% of ASDs in males. Taken together, these results provide compelling evidence that rare autosomal and X chromosome complete gene knockouts are important inherited risk factors for ASD.


Human Molecular Genetics | 2011

Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders

Christian P. Schaaf; Aniko Sabo; Yasunari Sakai; Jacy R. Crosby; Donna M. Muzny; Alicia Hawes; Lora Lewis; Humeira Akbar; Robin Varghese; Eric Boerwinkle; Richard A. Gibbs; Huda Y. Zoghbi

Autism spectrum disorders (ASDs) are a heterogeneous group of neuro-developmental disorders. While significant progress has been made in the identification of genes and copy number variants associated with syndromic autism, little is known to date about the etiology of idiopathic non-syndromic autism. Sanger sequencing of 21 known autism susceptibility genes in 339 individuals with high-functioning, idiopathic ASD revealed de novo mutations in at least one of these genes in 6 of 339 probands (1.8%). Additionally, multiple events of oligogenic heterozygosity were seen, affecting 23 of 339 probands (6.8%). Screening of a control population for novel coding variants in CACNA1C, CDKL5, HOXA1, SHANK3, TSC1, TSC2 and UBE3A by the same sequencing technology revealed that controls were carriers of oligogenic heterozygous events at significantly (P < 0.01) lower rate, suggesting oligogenic heterozygosity as a new potential mechanism in the pathogenesis of ASDs.


PLOS Genetics | 2013

Analysis of Rare, Exonic Variation amongst Subjects with Autism Spectrum Disorders and Population Controls

Li Liu; Aniko Sabo; Benjamin M. Neale; Uma Nagaswamy; Christine Stevens; Elaine T. Lim; Corneliu A. Bodea; Donna M. Muzny; Jeffrey G. Reid; Eric Banks; Hillary Coon; Mark A. DePristo; Huyen Dinh; Tim Fennel; Jason Flannick; Stacey Gabriel; Kiran Garimella; Shannon Gross; Alicia Hawes; Lora Lewis; Vladimir Makarov; Jared Maguire; Irene Newsham; Ryan Poplin; Stephan Ripke; Khalid Shakir; Kaitlin E. Samocha; Yuanqing Wu; Eric Boerwinkle; Joseph D. Buxbaum

We report on results from whole-exome sequencing (WES) of 1,039 subjects diagnosed with autism spectrum disorders (ASD) and 870 controls selected from the NIMH repository to be of similar ancestry to cases. The WES data came from two centers using different methods to produce sequence and to call variants from it. Therefore, an initial goal was to ensure the distribution of rare variation was similar for data from different centers. This proved straightforward by filtering called variants by fraction of missing data, read depth, and balance of alternative to reference reads. Results were evaluated using seven samples sequenced at both centers and by results from the association study. Next we addressed how the data and/or results from the centers should be combined. Gene-based analyses of association was an obvious choice, but should statistics for association be combined across centers (meta-analysis) or should data be combined and then analyzed (mega-analysis)? Because of the nature of many gene-based tests, we showed by theory and simulations that mega-analysis has better power than meta-analysis. Finally, before analyzing the data for association, we explored the impact of population structure on rare variant analysis in these data. Like other recent studies, we found evidence that population structure can confound case-control studies by the clustering of rare variants in ancestry space; yet, unlike some recent studies, for these data we found that principal component-based analyses were sufficient to control for ancestry and produce test statistics with appropriate distributions. After using a variety of gene-based tests and both meta- and mega-analysis, we found no new risk genes for ASD in this sample. Our results suggest that standard gene-based tests will require much larger samples of cases and controls before being effective for gene discovery, even for a disorder like ASD.

Collaboration


Dive into the Aniko Sabo's collaboration.

Top Co-Authors

Avatar

Donna M. Muzny

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Richard A. Gibbs

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Eric Boerwinkle

University of Texas Health Science Center at Houston

View shared research outputs
Top Co-Authors

Avatar

Alicia Hawes

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Lora Lewis

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Jacy R. Crosby

University of Texas Health Science Center at Houston

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David A. Wheeler

Baylor College of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge